BIOATLA, INC. Earnings Per Share (Diluted)
BIOATLA, INC. (BCAB) reported Earnings Per Share (Diluted) of $0.27 per share for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareDiluted · last filed 2026-08-13
- BIOATLA, INC. earnings per share, diluted for the quarter ending 2026-06-30 was $0.27.
- BIOATLA, INC. earnings per share, diluted for the quarter ending 2026-03-31 was -$4.22.
- BIOATLA, INC. earnings per share, diluted for the quarter ending 2025-12-31 was $1.83, a 27.14% decline year-over-year.
- BIOATLA, INC. earnings per share, diluted for the quarter ending 2025-09-30 was -$0.27.
- BIOATLA, INC. earnings per share, diluted for fiscal 2025 was -$1.01.
- BIOATLA, INC. earnings per share, diluted for fiscal 2024 was -$1.44.
- BIOATLA, INC. earnings per share, diluted for fiscal 2023 was -$2.58.
- BIOATLA, INC. earnings per share, diluted for fiscal 2022 was -$2.74.
| Period end | Earnings Per Share, Diluted 3 month | Earnings Per Share, Diluted 3 month as first filed | Earnings Per Share, Diluted 6 month | Earnings Per Share, Diluted 6 month as first filed | Earnings Per Share, Diluted 9 month | Earnings Per Share, Diluted 12 month |
|---|---|---|---|---|---|---|
| 2026-06-30 | $0.27 10-Q · filed 2026-08-13 | -$3.73 10-Q · filed 2026-08-13 | $4.93 derived: net income ÷ weighted average shares · filed 2026-08-13 | $2.88 derived: net income ÷ weighted average shares · filed 2026-08-13 | ||
| 2026-03-31 | -$4.22 10-Q · filed 2026-05-15 | $3.36 derived: net income ÷ weighted average shares · filed 2026-06-03 | $2.18 derived: net income ÷ weighted average shares · filed 2026-06-03 | $2.26 derived: net income ÷ weighted average shares · filed 2026-08-13 | ||
| 2025-12-31 | $1.83 derived: net income ÷ weighted average shares · filed 2026-06-03 | $1.58 derived: net income ÷ weighted average shares · filed 2026-06-03 | $1.88 derived: net income ÷ weighted average shares · filed 2026-08-13 | -$1.01 10-K · filed 2026-03-31 | ||
| 2025-09-30 | -$0.27 10-Q · filed 2025-11-13 | -$1.15 derived: net income ÷ weighted average shares · filed 2026-08-13 | -$0.85 10-Q · filed 2025-11-13 | $2.70 derived: net income ÷ weighted average shares · filed 2026-08-13 | ||
| 2025-06-30 | -$15.99 10-Q · filed 2026-08-13 | -$0.32 10-Q · filed 2025-08-07 | -$29.16 10-Q · filed 2026-08-13 | -$0.58 10-Q · filed 2025-08-07 | $5.23 derived: net income ÷ weighted average shares · filed 2026-08-13 | $3.19 derived: net income ÷ weighted average shares · filed 2026-08-13 |
| 2025-03-31 | -$13.16 10-Q · filed 2026-05-15 | -$0.26 10-Q · filed 2025-05-06 | $4.30 derived: net income ÷ weighted average shares · filed 2026-06-03 | $2.99 derived: net income ÷ weighted average shares · filed 2026-06-03 | $2.11 derived: net income ÷ weighted average shares · filed 2026-06-03 | |
| 2024-12-31 | $2.51 derived: net income ÷ weighted average shares · filed 2026-06-03 | $2.33 derived: net income ÷ weighted average shares · filed 2026-06-03 | $1.91 derived: net income ÷ weighted average shares · filed 2026-06-03 | -$1.44 10-K · filed 2026-03-31 | ||
| 2024-09-30 | -$0.22 10-Q · filed 2025-11-13 | -$0.66 derived: net income ÷ weighted average shares · filed 2025-11-13 | -$1.14 10-Q · filed 2025-11-13 | $3.43 derived: net income ÷ weighted average shares · filed 2026-06-03 | ||
| 2024-06-30 | -$0.44 10-Q · filed 2025-08-07 | -$0.92 10-Q · filed 2025-08-07 | $3.65 derived: net income ÷ weighted average shares · filed 2026-06-03 | $2.96 derived: net income ÷ weighted average shares · filed 2026-06-03 | ||
| 2024-03-31 | -$0.48 10-Q · filed 2025-05-06 | $4.10 derived: net income ÷ weighted average shares · filed 2026-06-03 | $3.41 derived: net income ÷ weighted average shares · filed 2026-06-03 | $2.67 derived: net income ÷ weighted average shares · filed 2026-06-03 | ||
| 2023-12-31 | $4.59 derived: net income ÷ weighted average shares · filed 2026-06-03 | $3.90 derived: net income ÷ weighted average shares · filed 2026-06-03 | $3.16 derived: net income ÷ weighted average shares · filed 2026-06-03 | -$2.58 10-K · filed 2025-03-28 | ||
| 2023-09-30 | -$0.70 10-Q · filed 2024-11-07 | -$1.45 derived: net income ÷ weighted average shares · filed 2024-11-07 | -$2.02 10-Q · filed 2024-11-07 | -$2.66 derived: net income ÷ weighted average shares · filed 2024-11-07 | ||
| 2023-06-30 | -$0.75 10-Q · filed 2024-08-08 | -$1.33 10-Q · filed 2024-08-08 | -$1.96 derived: net income ÷ weighted average shares · filed 2024-08-08 | -$2.64 derived: net income ÷ weighted average shares · filed 2024-08-08 | ||
| 2023-03-31 | -$0.58 10-Q · filed 2024-05-14 | -$1.21 derived: net income ÷ weighted average shares · filed 2024-05-14 | -$1.89 derived: net income ÷ weighted average shares · filed 2024-05-14 | -$2.64 derived: net income ÷ weighted average shares · filed 2024-05-14 | ||
| 2022-12-31 | -$0.63 derived: net income ÷ weighted average shares · filed 2024-03-26 | -$1.32 derived: net income ÷ weighted average shares · filed 2024-03-26 | -$2.08 derived: net income ÷ weighted average shares · filed 2024-03-26 | -$2.74 10-K · filed 2024-03-26 | ||
| 2022-09-30 | -$0.69 10-Q · filed 2023-11-07 | -$1.46 derived: net income ÷ weighted average shares · filed 2023-11-07 | -$2.11 10-Q · filed 2023-11-07 | -$2.74 derived: net income ÷ weighted average shares · filed 2023-11-07 | ||
| 2022-06-30 | -$0.77 10-Q · filed 2023-08-01 | -$1.42 10-Q · filed 2023-08-01 | -$2.06 derived: net income ÷ weighted average shares · filed 2023-08-01 | -$2.73 derived: net income ÷ weighted average shares · filed 2023-08-01 | ||
| 2022-03-31 | -$0.65 10-Q · filed 2023-05-11 | -$1.28 derived: net income ÷ weighted average shares · filed 2023-05-11 | -$1.96 derived: net income ÷ weighted average shares · filed 2023-05-11 | -$2.85 derived: net income ÷ weighted average shares · filed 2023-05-11 | ||
| 2021-12-31 | -$0.63 derived: net income ÷ weighted average shares · filed 2023-03-23 | -$1.31 derived: net income ÷ weighted average shares · filed 2023-03-23 | -$2.20 derived: net income ÷ weighted average shares · filed 2023-03-23 | -$2.76 10-K · filed 2023-03-23 | ||
| 2021-09-30 | -$0.68 10-Q · filed 2022-11-04 | -$1.58 derived: net income ÷ weighted average shares · filed 2022-11-04 | -$2.13 10-Q · filed 2022-11-04 | |||
| 2021-06-30 | -$0.90 10-Q · filed 2022-08-09 | -$1.46 10-Q · filed 2022-08-09 | ||||
| 2020-12-31 | -$3.19 derived: net income ÷ weighted average shares · filed 2022-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| EXOZYMES INC. (EXOZ) | United States | $0.058B | |
| ImageneBio, Inc. (IMA) | United States | $0.056B | -1.31 |
| Inmune Bio, Inc. (INMB) | United States | $0.056B | -2.48 |
| MiNK Therapeutics, Inc. (INKT) | United States | $0.063B | -5.37 |
| Eloxx Pharmaceuticals, Inc. (ELOX) | United States | $0.065B | |
| Tevogen Inc. (TVGN) | United States | $0.049B | |
| Instil Bio, Inc. (TIL) | United States | $0.048B | -1.73 |
| LeonaBio, Inc. (LONA) | United States | $0.047B | -0.61 |
| BioStem Technologies, Inc. (BSEM) | United States | $0.069B | |
| CHAMPIONS ONCOLOGY, INC. (CSBR) | United States | $0.070B | -68.02 |